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Abstract
Background: One of the limitations of antibiotic therapy is that even after successful killing of the
infecting microorganism, virulence factors may still be present and cause significant damage to the
host. Light-activated antimicrobials show potential for the treatment of topical infections; therefore
if these agents can also inactivate microbial virulence factors, this would represent an advantage
over conventional antibiotic therapy. Staphylococcus aureus produces a wide range of virulence
factors that contribute to its success as a pathogen by facilitating colonisation and destruction of
host tissues.
Results: In this study, the ability of the light-activated antimicrobial agent methylene blue in
combination with laser light of 665 nm to inactivate staphylococcal virulence factors was assessed.
A number of proteinaceous virulence factors were exposed to laser light in the presence of
methylene blue and their biological activities re-determined. The activities of V8 protease, α-
haemolysin and sphingomyelinase were shown to be inhibited in a dose-dependent manner by
exposure to laser light in the presence of methylene blue.
Conclusion: These results suggest that photodynamic therapy could reduce the harmful impact
of preformed virulence factors on the host.
Background
Staphylococcus aureus is a versatile opportunistic pathogen
that causes a variety of infections ranging from superficial
skin infections to severe, invasive diseases such as bacter-
aemia and necrotising pneumonia [1]. Its success as a
human pathogen is highlighted by the fact that despite the
development of antibiotic therapy, the frequency of sta-
phylococcal bacteraemias is increasing [2]. Developments
in medicine can at least be partly attributed to this rise as
an increasing number of staphylococcal infections are
related to the use of joint prostheses, immunosuppres-
sants and catheters [3]. Indeed, S. aureus is the most fre-
quent cause of surgical site infections, accounting for 38%
of infections reported in the UK during the period January
2003 to December 2007 [4].
Methicillin-resistant S. aureus (MRSA) accounts for a high
proportion of surgical site infections caused by S. aureus,
being responsible for 64% of such infections in 2007/
2008 [4]. Fewer than 5% of S. aureus isolates are now sen-
sitive to penicillin, once the drug of choice for staphyloco-
ccal infections [5]. MRSA was first reported in the United
Kingdom just two years after the introduction of methicil-
lin in 1959 [6]. Horizontal transfer of the mecA  gene,
which encodes a penicillin-binding protein, results in
resistance not only to methicillin, but also to broad spec-
trum  β-lactams such as the third-generation cepha-
losporins, cefamycins and carbapenems [7]. The
proportion of MRSA isolates from blood cultures taken
from cases of bacteraemia in England has risen dramati-
cally from less than 5% in 1990 to around 40% by the end
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of the 1990s [4]. As well as mortality rates of almost dou-
ble those associated with methicillin-sensitive S. aureus
(MSSA) infections, MRSA has put a considerable financial
burden on both hospitals and society in general [8].
Over 40 different virulence factors have been identified in
S. aureus; these are involved in almost all processes from
colonisation of the host to nutrition and dissemination
[9]. S. aureus produces a wide range of enzymes and toxins
that are thought to be involved in the conversion of host
tissues into nutrients for bacterial growth [10] in addition
to having numerous modulatory effects on the host
immune response [11].
The increasing resistance of pathogenic bacteria such as S.
aureus to antibiotics has led to the search for new antimi-
crobial strategies, and photodynamic therapy (PDT) is
emerging as a promising alternative. The photodynamic
inactivation of bacteria relies upon the capacity of a light-
activated antimicrobial agent (or "photosensitiser") to
generate reactive oxygen species on irradiation with light
of a suitable wavelength. Reactive oxygen species can oxi-
dise many biological structures such as proteins, nucleic
acids and lipids. As the mechanism of action of microbial
killing is non-specific and multiple sites are affected, it is
considered unlikely that resistance will evolve [12], thus
representing a significant advantage over conventional
antibiotic treatment where resistance is an ever-increasing
problem. A very desirable feature of PDT is the potential
for inactivation of virulence factors, particularly secreted
proteins, by reactive oxygen species [13].
The biological activities of some virulence factors pro-
duced by Gram-negative bacteria have been shown to be
successfully reduced by photodynamic action. The inhib-
itory effect of red laser light and the photosensitiser Tolu-
idine Blue O (TBO) on virulence factors from Escherichia
coli, Pseudomonas aeruginosa [14] and Porphyromonas gingi-
valis [15] has previously been demonstrated; however the
effect on staphylococcal virulence factors has not been
investigated.
In this study, we have investigated the effect of photosen-
sitisation using methylene blue and laser light of 665 nm
on some of the key virulence factors of S. aureus. The use
of methylene blue is well established in medicine where it
is used for the routine staining of vital organs and the
treatment of septic shock [16].
Results
EMRSA-16
Methylene blue and laser light of 665 nm was found to
successfully kill EMRSA-16, as shown by Figures 1 and 2.
Treatment of EMRSA-16 with 20 μM methylene blue and
a laser light dose of 1.93 J/cm2 resulted in an approximate
4-log reduction in viability, corresponding to 99.98% kill.
After irradiation with 9.65 J/cm2 laser light in the presence
of 20 μM methylene blue, an approximate 6-log reduction
in viability was achieved, corresponding to a 99.999%
kill, demonstrating the effectiveness of this regimen
against MRSA.
V8 protease
The effect of methylene blue and laser light on the prote-
olytic activity of the V8 protease as determined by the azo-
casein-hydrolysis assay is shown in Figures 3 and 4. One
unit of activity was defined as that which caused a change
in absorbance of 0.001 in one hour at 450 nm. Figure 3
shows that the activity of the V8 protease was inhibited in
a photosensitiser concentration-dependent manner, with
a decrease in proteolytic activity of 75% being achieved
with the highest concentration of methylene blue tested
(20 μM) upon irradiation for 1 minute with laser light
(1.93 J/cm2). Photosensitisation of EMRSA-16 using the
same conditions resulted in an approximate 4-log reduc-
tion in viability, showing that inactivation of this enzyme
is effective within the parameters required to kill S. aureus
in vitro. Figure 4 shows the effect of light dose on the activ-
ity of the V8 protease after exposure to laser light for 1, 2
and 5 minutes, corresponding to energy densities of 1.93
J/cm2, 3.86 J/cm2 and 9.65 J/cm2 respectively. Inactivation
was also seen to be light dose-dependent and a 100%
reduction in proteolytic activity was achieved following 5
minutes irradiation with laser light in the presence of 20
μM methylene blue. Neither laser light nor methylene
Lethal photosensitisation of EMRSA-16 with 1, 5, 10 and 20  μM methylene blue and a 665 nm laser light dose of 1.93 J/ cm2 Figure 1
Lethal photosensitisation of EMRSA-16 with 1, 5, 10 
and 20 μM methylene blue and a 665 nm laser light 
dose of 1.93 J/cm2. An equal volume of either PBS (S-) or 
methylene blue (S+) (concentrations ranging from 1-20 μM) 
was added to 50 μL of the bacterial suspension and either 
kept in the dark (L-) (white bars) or exposed to 665 nm laser 
light with an energy density of 1.93 J/cm2 (L+) (black bars). 
After irradiation/dark incubation, samples were serially 
diluted and the surviving CFU/mL enumerated. Error bars 
represent the standard deviation from the mean. *** P < 
0.001 (Mann Whitney U test). Experiments were performed 
three times in triplicate and the combined data are shown.
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blue alone had an inhibitory effect on the activity of the
V8 protease. SDS PAGE analysis (Figure 5) showed that
after exposure to laser light and methylene blue, the bands
derived from the V8 protease appeared to be progressively
more smeared and of lower intensity with increased irra-
diation time, demonstrating that photosensitisation may
cause a change in the protein, perhaps due to oxidation of
the protein. A band of 29 kDa was expected for the V8 pro-
tease; however the gel showed some degradation of the V8
protease that could not be inhibited by the addition of a
protease inhibitor.
α-haemolysin
Table 1 shows the effect of photosensitisation of α-
haemolysin with 1, 5, 10 and 20 μM methylene blue and
laser light. Concentrations of 5, 10 and 20 μM methylene
blue completely inhibited the haemolytic activity of the
enzyme when exposed to laser light (L+); therefore inacti-
vation of the toxin occurs even at photosensitiser doses
that are sub-inhibitory to EMRSA-16 (i.e. 5 μM). There
was no effect on the activity when the enzyme was incu-
bated with the methylene blue in the absence of laser light
(L-). To investigate the effect of light dose on the activity
of  α-haemolysin, the enzyme was exposed to 20 μM
methylene blue and irradiated with 665 nm laser light for
1, 2 and 5 minutes. Table 2 shows that the activity of the
enzyme was completely inhibited after exposure to a light
dose of 1.93 J/cm2 in the presence of 20 μM methylene
blue, and further investigation showed that a laser light
dose as low as 0.64 J/cm2 results in the complete inhibi-
tion of haemolytic activity when treated with 20 μM
methylene blue (data not shown). Laser light alone had
no appreciable effect on the activity of the α-haemolysin.
SDS PAGE analysis (Figure 6) showed that bands derived
from the α-haemolysin after photosensitisation with 20
μM methylene blue and laser light became less well
defined and smeared with increasing irradiation time
compared to untreated samples. This result is similar to
that observed for the V8 protease. The addition of 12.5%
human serum did not affect the ability of photosensitisa-
tion to inactivate the α-haemolysin, and complete inhibi-
tion of haemolytic activity was observed after treatment of
the toxin with 20 μM methylene blue and a laser light
dose of 1.93 J/cm2 in the presence of serum. This finding
is consistent with the inactivation of the toxin in the
absence of serum.
Sphingomyelinase
The activity of S. aureus sphingomyelinase was inhibited
by treatment with methylene blue and laser light in a
dose-dependent manner, as shown in Figures 7 and 8.
One unit of activity was defined as that which caused a
change in absorbance of 0.001 in one minute at 330 nm.
Interestingly, laser light alone appeared to have a slight
effect on the activity of the enzyme, although this was not
statistically significant (P > 0.05). Irradiation with 1.93 J/
The effect of 20 μM methylene blue and laser light doses of  1.93 J/cm2, 3.86 J/cm2 and 9.65 J/cm2 on the lethal photosensi- tisation of EMRSA-16 Figure 2
The effect of 20 μM methylene blue and laser light 
doses of 1.93 J/cm2, 3.86 J/cm2 and 9.65 J/cm2 on the 
lethal photosensitisation of EMRSA-16. An equal vol-
ume of either PBS (S-) (white bars) or 20 μM methylene blue 
(S+) (black bars) was added to 50 μL of the bacterial suspen-
sion and either kept in the dark (L-) or exposed to 665 nm 
laser light for 1, 2 and 5 minutes, corresponding to energy 
densities of 1.93 J/cm2, 3.86 J/cm2 and 9.65 J/cm2 (L+). After 
irradiation/dark incubation, samples were serially diluted and 
the surviving CFU/mL enumerated. Error bars represent the 
standard deviation from the mean. *** P < 0.001 (Mann 
Whitney U test). Experiments were performed three times 
in triplicate and the combined data are shown.
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The effect of methylene blue dose and 1.93 J/cm2 laser light  on the proteolytic activity of V8 protease Figure 3
The effect of methylene blue dose and 1.93 J/cm2 
laser light on the proteolytic activity of V8 protease. 
An equal volume of either methylene blue (S+) (concentra-
tions ranging from 1-20 μM) or PBS (S-) was added to V8 
protease and samples were either exposed to laser light with 
an energy density of 1.93 J/cm2 (L+) (black bars) or kept in 
the dark (L-) (white bars). The activity of the V8 protease 
was assessed using the azocasein hydrolysis assay. Error bars 
represent the standard deviation from the mean. *** P < 
0.001 (ANOVA). Experiments were performed three times 
in triplicate and the combined data are shown.
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cm2 laser light in the presence of 20 μM methylene blue
achieved a 76% decrease in the activity of sphingomyeli-
nase, which is comparable to the decrease in activity seen
for the V8 protease (75%); these photosensitisation con-
ditions correspond to an approximate 4-log reduction in
viable EMRSA-16 and therefore inactivation is effective
with light and energy doses required for the effective kill-
ing of bacteria. After irradiation with 9.65 J/cm2 laser light
in the presence of 20 μM methylene blue, a decrease in
activity of 92% was observed. Neither dark incubation of
the enzyme with the photosensitiser alone nor irradiation
in the absence of methylene blue had a significant effect
on the activity of the sphingomyelinase. Irradiation of the
sphingomyelinase in the presence of 12.5% human serum
did not have an effect on the ability of photosensitisation
to inactivate the enzyme. Photosensitisation using 20 μM
methylene blue and the lowest laser light dose (1.93 J/
cm2) resulted in a decrease in the enzyme's activity of 70%
± 12% in the presence of human serum, compared to a
decrease of 76% ± 10% in the absence of serum. This dif-
ference was not found to be statistically significant (P >
0.05, ANOVA).
Discussion
Packer et al. [15] demonstrated that proteolytic enzymes
of the periodontal pathogen Porphyromonas gingivalis
could be inactivated using the photosensitiser Toluidine
Blue O and red laser light with a wavelength of 633 nm.
Table 1: The effect of treatment of α-haemolysin with different concentrations of methylene blue and a laser light dose of 1.93 J/cm2.
Concentration of methylene blue (μM) Haemolytic titre
L-
Haemolytic titre
L+
1 1/1024 1/256
5 1/1024 1/2
10 1/1024 < 1/2
20 1/512 1/2
An equal volume of either 1, 5, 10 and 20 μM methylene blue or PBS was added to S. aureus α-haemolysin and samples were either exposed to 1.93 
J/cm2 laser light (L+) or kept in the dark (L-). After irradiation/dark incubation, samples were serially diluted and an equal volume of 4% rabbit 
erythrocytes was added. Following incubation in the dark at 37°C for one hour, the haemolytic titre was recorded. The haemolytic titre is defined 
as the highest dilution giving rise to haemolysis. Experiments were performed twice in duplicate and a representative experiment is shown.
SDS PAGE analysis of V8 protease irradiated with methylene  blue and laser light doses of 1.93 J/cm2, 3.86 J/cm2 and 9.65 J/ cm2 Figure 5
SDS PAGE analysis of V8 protease irradiated with 
methylene blue and laser light doses of 1.93 J/cm2, 
3.86 J/cm2 and 9.65 J/cm2. V8 protease was either kept in 
the dark (L-) or irradiated with laser light doses of 1.93 J/cm2, 
3.86 J/cm2 and 9.65 J/cm2 (L+) in the presence of an equal vol-
ume of either PBS (S-) or 20 μM methylene blue (S+). Fol-
lowing irradiation, samples were analysed by SDS PAGE using 
a 5% stacking gel and 15% resolving gel under denaturing 
conditions. Lane 1: molecular weight marker, lane 2: L-S-, 
lane 3: L-S+, lane 4: L+S- (1.93 J/cm2), lane 5: L+S- (3.86 J/
cm2), lane 6: L+S- (9.65 J/cm2), lane 7: L+S+ (1.93 J/cm2), lane 
8: L+S+ (3.86 J/cm2), lane 9: L+S+ (9.65 J/cm2). L = samples 
exposed to laser light and S = samples exposed to 20 μM 
methylene blue. The apparent molecular mass of the V8 pro-
tease was approximately 30 kDa.
1         2        3        4       5       6       7       8  9      
30 KDa
25 KDa
The effect of 20 μM methylene blue and different laser light  doses on the proteolytic activity of V8 protease Figure 4
The effect of 20 μM methylene blue and different 
laser light doses on the proteolytic activity of V8 pro-
tease. V8 protease was either kept in the dark (L-) or irradi-
ated with laser light doses of 1.93 J/cm2, 3.86 J/cm2 and 9.65 J/
cm2 (L+) in the presence of an equal volume of either PBS (S-
) (white bars) or 20 μM methylene blue (S+) (black bars). 
Following irradiation, the activity of the enzyme was assessed 
using the azocasein hydrolysis assay. Error bars represent the 
standard deviation from the mean. *** P < 0.001 (ANOVA). 
Experiments were performed three times in triplicate and 
the combined data are shown.
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The results presented here support these findings, with a
highly significant reduction in the activity of S. aureus V8
protease being achieved with a light dose as low as 1.93 J/
cm2 in combination with a low (20 μM) concentration of
methylene blue. This inactivation was found to be dose-
dependent, with the highest concentration of methylene
blue tested (20 μM) and irradiation with 9.65 J/cm2 laser
light achieving a 100% reduction in activity compared to
non-treated samples. Treatment of EMRSA-16 under the
same conditions resulted in a 99.999% kill, indicating
that inactivation of secreted proteases may be possible as
well as eradicating infecting bacteria.
Proteases are responsible for the destruction of host tis-
sues both directly and indirectly; inactivation of these
enzymes using PDT could therefore limit the damage to
the host, as well as killing the infecting organism. It has
been suggested that theV8 protease plays an important
role in the pathogenesis of S. aureus, as strains lacking this
enzyme show reduced virulence in a number of infection
models [17-19]. Of particular relevance is a murine
abscess model, in which inactivation of V8 protease
resulted in significant attenuation of virulence [18]; there-
fore inactivation of this enzyme by PDT may be able to
reduce the virulence potential of S. aureus in other hosts.
As staphylococcal proteases and the colonisation of atopic
skin by S. aureus have been implicated in the pathogenic-
ity of atopic dermatitis [20], the inactivation of proteolytic
enzymes could have particular relevance for the decon-
tamination of infected lesions using PDT. PDT using the
combination of methylene blue and laser light of 665 nm
may therefore be of use in the treatment of atopic skin dis-
orders. In fact, PDT has long been shown to be beneficial
in the treatment of atopic skin disorders, for example the
use of ultraviolet light and 8-methoxypsoralen for the
treatment of atopic dermatitis [21]. Clearly, the combina-
tion of elimination of disease-exacerbating microorgan-
Table 2: The effect of light dose on the activity of α-haemolysin 
when treated with 20 μM methylene blue
Light Dose (J/cm2) Haemolytic titre
S-
Haemolytic titre
S+
0 1/512 1/512
1.93 1/256 < 1/2
3.86 1/256 < 1/2
9.65 1/256 < 1/2
An equal volume of either 20 μM methylene blue (S+) or PBS (S-) was 
added to S. aureus α-haemolysin and samples were either exposed to 
laser light doses of 1.93 J/cm2, 3.86 J/cm2 and 9.65 J/cm2 (L+) or kept 
in the dark (L). After irradiation/dark incubation, samples were 
serially diluted and an equal volume of 4% rabbit erythrocytes was 
added. Following incubation in the dark at 37°C for one hour, the 
haemolytic titre was recorded. The haemolytic titre is the highest 
dilution giving rise to haemolysis. Experiments were performed twice 
in triplicate and a representative experiment is shown.
SDS PAGE analysis of α-haemolysin irradiated with 20 μM  methylene blue and laser light doses of 1.93 J/cm2, 3.86 J/cm2  and 9.65 J/cm2 Figure 6
SDS PAGE analysis of α-haemolysin irradiated with 
20 μM methylene blue and laser light doses of 1.93 J/
cm2, 3.86 J/cm2 and 9.65 J/cm2. α-haemolysin was either 
kept in the dark (L-) or irradiated with laser light doses of 
1.93 J/cm2, 3.86 J/cm2 and 9.65 J/cm2 (L+) in the presence of 
an equal volume of either PBS (S-) or 20 μM methylene blue 
(S+) Following irradiation, samples were analysed by SDS 
PAGE using a 5% stacking gel and 15% resolving gel under 
denaturing conditions. Lane 1: molecular weight marker, lane 
2: L-S-, lane 3: L-S+, lane 4: L+S- (1.93 J/cm2), lane 5: L+S- 
(3.86 J/cm2), lane 6: L+S- (9.65 J/cm2), lane 7: L+S+ (1.93 J/
cm2), lane 8: L+S+ (3.86 J/cm2), lane 9: L+S+ (9.65 J/cm2). L = 
samples exposed to laser light and S = samples exposed to 20 
μM methylene blue. The apparent molecular mass of α-
haemolysin was approximately 29 kDa.
1         2        3         4         5        6       7    8        9
30 kDa
25 kDa
The effect of methylene blue dose when irradiated with 1.93  J/cm2 laser light on the activity of S. aureus sphingomyelinase Figure 7
The effect of methylene blue dose when irradiated 
with 1.93 J/cm2 laser light on the activity of S. aureus 
sphingomyelinase. An equal volume of either 1, 5, 10 and 
20 μM methylene blue (S+) or PBS (S-) was added to sphin-
gomyelinaseand samples were either exposed to laser light 
with an energy density of 1.93 J/cm2 (L+) (black bars) or kept 
in the dark (L-) (white bars). Following irradiation, the activ-
ity of the enzyme was assessed spectrophotometrically using 
the substrate TNPAL-Sphingomyelin. Error bars represent 
the standard deviation from the mean. *** P < 0.001 
(ANOVA). Experiments were performed three times in 
duplicate and the combined data are shown.
0
20
40
60
80
100
120
140
015 1 0 2 0
Concentration of methylene blue (μ μ μ μM)
U
n
i
t
s
 
o
f
 
a
c
t
i
v
i
t
y
L-
L+
**
*BMC Microbiology 2009, 9:211 http://www.biomedcentral.com/1471-2180/9/211
Page 6 of 10
(page number not for citation purposes)
isms and neutralisation of virulence factors would be
extremely advantageous to the treatment of these diseases.
The treatment of α-haemolysin with methylene blue and
laser light resulted in an effective inhibition of haemolytic
activity. Concentrations of methylene blue ranging from
1-20 μM all had an inhibitory effect on α-haemolysin
when irradiated with laser light, and α-haemolysin was
shown to be inactivated after an irradiation time of just 1
minute (1.93 J/cm2) when in the presence of 20 μM meth-
ylene blue. The results shown here demonstrate that α-
haemolysin is the most susceptible of the virulence factors
tested, perhaps due to the nature of its amino acid compo-
sition, which may leave it more vulnerable to attack by
reactive oxygen species. These data indicate that photody-
namic inactivation of this toxin is highly effective and as
such, could significantly attenuate the virulence of S.
aureus due to the multiple functions of α-haemolysin as a
virulence factor.
The haemolysins of S. aureus are membrane-damaging
toxins that are capable of lysing a number of different cell
types. α-haemolysin is thought to be important in infec-
tion as it has a number of detrimental effects on host cells
due to the disruption of ion transport across host cell
membranes, ultimately leading to apoptotic cell death
and oedema [10]. α-haemolysin can cause cell death in
different ways depending on the concentration of the
toxin. At high concentrations, α-haemolysin forms large
pores in lipid bilayers that result in massive necrosis,
whilst low doses result in the formation of small pores
that result in apoptosis and DNA fragmentation [22]. The
role of α-haemolysin in the virulence of S. aureus has been
demonstrated in a number of infection models such as
mastitis [23] and pneumonia [24]. It has also been pro-
posed that α-haemolysin may play a role in colonisation
of epithelia by attenuating bacterial clearance from the
epithelial surface [25]; this could therefore be of relevance
to the decontamination of nasal epithelia using PDT. In
addition, α-haemolysin has immunomodulatory proper-
ties, notably its ability to trigger the release of pro-inflam-
matory cytokines such as interleukin-1β [26]; thus
inactivation of α-haemolysin by PDT may also protect
against harmful inflammatory processes as well as elimi-
nating infecting organisms.
The treatment of S. aureus sphingomyelinase with laser
light and methylene blue resulted in a significant, dose-
dependent reduction in the enzyme's activity. Laser light
alone also appeared to reduce the activity of sphingomy-
elinase; however this was found to be not statistically sig-
nificant. Irradiation of sphingomyelinase with 1.93 J/cm2
laser light in the presence of the highest concentration of
methylene blue tested (20 μM) achieved a highly signifi-
cant reduction in the activity of the enzyme (76%), which
was comparable to the reduction in activity observed for
the V8 protease when irradiated for the same time period.
This reduction in activity was increased to 92% after irra-
diation of the enzyme for 5 minutes in the presence of 20
μM methylene blue. Production of sphingomyelinase (β-
haemolysin) is thought to be of importance in severe,
chronic skin infections, and strains of S. aureus producing
high levels of this enzyme have been shown to cause more
intense skin lesions than low-producing strains [27]. Inac-
tivation of these toxins may therefore be of notable rele-
vance to the treatment of superficial staphylococcal skin
infections. Sphingomyelinase has recently been shown to
kill proliferating T lymphocytes, suggesting a role for this
toxin in evasion of the host immune response [28]; hence
inactivation of sphingomyelinase by PDT could also
reduce the immunomodulatory properties of S. aureus.
The photodynamic inactivation of α-haemolysin and
sphingomyelinase was shown to be unaffected by the
presence of human serum at concentrations resembling
the protein content of an acute wound[29], indicating
that photodynamic therapy may be effective in inactivat-
ing these virulence factors in vivo. Together with the data
showing that PDT using methylene blue and 665 nm laser
light is effective against a methicillin-resistant strain of S.
aureus, this supports the potential of PDT as a treatment
for superficial staphylococcal infections.
The effect of 20 μM methylene blue when irradiated with dif- ferent laser light doses on the activity of S. aureus sphingomy- elinase Figure 8
The effect of 20 μM methylene blue when irradiated 
with different laser light doses on the activity of S. 
aureus sphingomyelinase. Sphingomyelinase was either 
kept in the dark (L-) or irradiated with laser light doses of 
1.93 J/cm2, 3.86 J/cm2 and 9.65 J/cm2 (L+) in the presence of 
an equal volume of either PBS (S-) (white bars) or 20 μM 
methylene blue (S+) (black bars). Following irradiation with 
laser light doses of 1.93 J/cm2, 3.86 J/cm2 and 9.65 J/cm2, the 
activity of the enzyme was assessed spectrophotometrically 
using the substrate TNPAL-Sphingomyelin. Error bars repre-
sent the standard deviation from the mean. *** P < 0.001 
(ANOVA). Experiments were performed three times in trip-
licate and the combined data are shown.
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The precise mechanism of inhibition of these virulence
factors has not yet been determined; however it is possible
that the reactive oxygen species formed during photosen-
sitisation can oxidise proteins, thereby disrupting their
function [13]. Oxidation of active site groups has been
suggested as the mechanism of action for the photody-
namic inactivation of the proteolytic enzymes of P. gingi-
valis [15]. SDS PAGE analysis of the V8 protease and α-
haemolysin demonstrated that photosensitisation caused
changes to the proteins which resulted in smearing of the
protein bands. We propose that singlet oxygen may play a
role in the inactivation of V8 protease as a protective effect
is observed when photosensitisation is performed in the
presence of the singlet oxygen scavenger L-tryptophan
(data not shown).
Conclusion
In conclusion, the results of this study suggest that photo-
sensitisation with methylene blue and laser light of 665
nm may be able to reduce the virulence potential of S.
aureus, as well as effectively killing the organism. Inactiva-
tion of α-haemolysin and sphingomyelinase is not
affected by the presence of human serum, indicating that
PDT may be effective against these toxins in vivo. Consid-
ering the extensive damage virulence factors can cause to
host tissues, the ability to inhibit their activity would be a
highly desirable feature for any antimicrobial treatment
regimen and would represent a significant advantage over
conventional antibiotic strategies.
Methods
Light source
A Periowave™ laser (Ondine Biopharma Inc., Canada),
which emits light with a wavelength of 665 nm was used
for all irradiation experiments. For experimental pur-
poses, the laser system was set up to give a power density
of 32 mW/cm2. The power output of the laser was meas-
ured using a thermopile power meter (TPM-300CE,
Genetic, Canada) and was found to be 73 mW at the plate
surface.
Photosensitiser
Methylene blue (C16H18ClN3S.3H2O) was purchased
from Sigma-Aldrich (UK). Stock solutions of 0.1 mg/ml
were prepared in phosphate buffered saline (PBS) and
kept in the dark at room temperature.
Bacterial strains
EMRSA-16 was maintained by weekly subculture on
Blood Agar (Oxoid Ltd, UK), supplemented with 5%
horse blood (E & O Laboratories Ltd). For experimental
purposes, bacteria were grown aerobically in Brain Heart
Infusion broth (Oxoid Ltd, UK) at 37°C for 16 hours in a
shaking incubator at 200 rpm. Cultures were centrifuged
and resuspended in an equal volume of PBS and the opti-
cal density was adjusted to 0.05 at 600 nm, corresponding
to approximately 1 × 107 colony forming units (CFU) per
mL.
The effect of photosensitiser dose on the lethal 
photosensitisation of EMRSA-16
Methylene blue was diluted in PBS to give final concentra-
tions of 1, 5, 10 and 20 μM. 50 μL of methylene blue was
added to an equal volume of the inoculum in triplicate
wells of a sterile, flat-bottomed, untreated 96-well plate
and irradiated with 665 nm laser light with an energy den-
sity of 1.93 J/cm2 (L+S+), with stirring. Three additional
wells containing 50 μL methylene blue and 50 μL of the
bacterial suspension were kept in the dark to assess the
toxicity of the photosensitiser alone (L-S+). 50 μL PBS was
also added to 50 μL of the inoculum in a further six wells,
three of which were irradiated with laser light as above
(L+S-) and the remaining three were kept in the dark (L-S-
). Following irradiation/dark incubation, each sample was
serially diluted 10-fold in PBS. 10 μL of each dilution was
spotted onto 5% horse blood agar plates in triplicate and
the plates incubated aerobically overnight at 37°C. The
surviving CFU/mL were enumerated by viable counting.
Experiments were performed three times in triplicate.
The effect of laser light dose on the lethal 
photosensitisation of EMRSA-16
Methylene blue was diluted in PBS to give a final concen-
tration of 20 μM. 50 μL of methylene blue was added to
an equal volume of the inoculum in triplicate wells of a
sterile, flat-bottomed, untreated 96-well plate and irradi-
ated with 665 nm laser light with energy densities of 1.93
J/cm2, 3.86 J/cm2 or 9.65 J/cm2, corresponding to 1, 2 or
5 minutes irradiation respectively, with stirring (L+S+).
Three additional wells containing 50 μL methylene blue
and 50 μL of the bacterial suspension were kept in the
dark (L-S+) and 50 μL PBS was also added to 50 μL of the
inoculum in a further six wells, three of which were irradi-
ated with laser light (L+S-) and the remaining three were
kept in the dark (L-S-). Following irradiation/dark incuba-
tion, each sample was serially diluted 10-fold in PBS. 10
μL of each dilution was spotted onto 5% horse blood agar
plates in triplicate and the plates incubated aerobically
overnight at 37°C. The surviving CFU/mL were enumer-
ated by viable counting. Experiments were performed
three times in triplicate.
Azocasein hydrolysis assay
Endoproteinase Glu-C (also known as V8 protease) from
S. aureus V8 was purchased from Sigma-Aldrich (UK) and
stored at -20°C at a concentration of 1 mg/mL in dH2O.
A final concentration of 5 μg/mL was obtained by diluting
the enzyme in PBS after preliminary experiments to deter-
mine the appropriate concentration for the assay condi-
tions. 50 μL of V8 protease was added to an equal volumeBMC Microbiology 2009, 9:211 http://www.biomedcentral.com/1471-2180/9/211
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of either methylene blue (S+) or PBS (S-) in triplicate
wells of a 96-well plate and samples were irradiated with
laser light (L+) or incubated in the dark (L-). For photo-
sensitiser dose experiments, final concentrations of 1, 5,
10 and 20 μM methylene blue were used and samples
were irradiated with 665 nm laser light with an energy
density of 1.93 J/cm2. For laser light dose experiments, a
final concentration of 20 μM methylene blue was used
and samples were irradiated with 665 nm laser light for
either 1, 2 or 5 minutes, corresponding to energy densities
of 1.93 J/cm2, 3.86 J/cm2 or 9.65 J/cm2.
After irradiation, the azocasein hydrolysis assay (modified
from [15]) was performed. 100 μL was removed from
each well and added to 50 μL of 6% azocasein (w/v) in 0.5
M Tris buffer, pH 7 (Sigma-Aldrich, UK) in 0.5 mL Eppen-
dorf tubes. Samples were incubated in the dark for one
hour at 37°C. The reaction was stopped with an equal vol-
ume of 20% acetic acid and the samples centrifuged for 10
minutes at 5590 × g. 75 μL of the supernatant was
removed in duplicate and the optical density read at 450
nm using a Dynex plate reader. The enzyme activity at one
hour was calculated for each sample; one unit of activity
was determined as that which caused a change in absorb-
ance of 0.001 in one hour at 450 nm. Photosensitiser and
light dose experiments were performed three times in trip-
licate.
Haemolytic titration
α-haemolysin from S. aureus was purchased from Sigma-
Aldrich (UK) and stored at 2-8°C at a concentration of 0.5
mg/mL in sterile, deionised water plus sodium citrate
buffer. For experimental purposes, α-haemolysin was
diluted in sterile PBS to a final concentration of 100 μg/
mL after preliminary experiments to determine the appro-
priate concentration for the assay conditions and accord-
ing to Bhakdi et al. [30]. For photosensitiser dose
experiments, the stock solution of methylene blue was
diluted in PBS to give final concentrations of 1, 5, 10 and
20 μM. 50 μL of methylene blue was added to an equal
volume of α-haemolysin in duplicate wells of a sterile,
flat-bottomed, untreated 96-well plate and irradiated with
laser light for 1 minute, corresponding to an energy dose
of 1.93 J/cm2 (L+S+). Two additional wells containing 50
μL methylene blue and 50 μL of the α-haemolysin were
kept in the dark to assess the effect of the photosensitiser
alone (L-S+). 50 μL PBS was also added to 50 μL of the α-
haemolysin in a further four wells, two of which were irra-
diated with laser light (L+S-) and the remaining two kept
in the dark (L-S-). For laser light dose experiments, a final
concentration of 20 μM methylene blue was used and
samples were irradiated with 665 nm laser light for either
1, 2 or 5 minutes, corresponding to energy densities of
1.93 J/cm2, 3.86 J/cm2 or 9.65 J/cm2. Following irradia-
tion/dark incubation, samples were removed and aliq-
uoted into round-bottomed 96-well plates for the
haemolytic titration assay.
For the haemolytic titration assay, samples were serially
diluted using doubling dilutions in PBS. Sterile, deionised
water was used as a positive control and sterile PBS as a
negative control. Defibrinated rabbit blood (E & O Labo-
ratories, UK) was centrifuged at 503 × g for 10 minutes
and the supernatant discarded. The cells were washed and
resuspended in sterile PBS to a final concentration of 2%.
50 μL was added to the serially diluted toxin and control
wells and incubated in the dark at 37°C for 1 hour. After
incubation, the haemolytic titre for each sample was
determined as the highest dilution giving rise to lysis.
Photosensitiser dose experiments were performed twice in
duplicate and light dose experiments were performed
twice in triplicate
The effect of human serum on the photosensitisation of S. 
aureus α-haemolysin
α-haemolysin was diluted to a final concentration of 100
μg/mL in either PBS or PBS + 12.5% human serum (Sigma
Aldrich, UK) in order to determine the effect of serum on
the photoinactivation of the toxin. 12.5% serum was
added to model in vivo conditions as this concentration
provided a protein concentration similar to that found in
an acute wound [29]. α-haemolysin in either the presence
or absence of human serum was exposed to 20 μM meth-
ylene blue and laser light with energy densities of 1.93 J/
cm2, 3.86 J/cm2 or 9.65 J/cm2 and the haemolytic titration
assay was performed as previously described. Experiments
were performed twice in triplicate.
Spectrophotometric assay for sphingomyelinase activity
Sphingomyelinase (also known as β-haemolysin or β-
toxin) from S. aureus was purchased from Sigma-Aldrich
(UK) in buffered aqueous glycerol containing 0.25 M
phosphate buffer, pH 7.5. For experimental purposes, the
enzyme was diluted to a final concentration of 0.5 Units/
mL in 250 mM Tris-HCl buffer with 10 mM magnesium
chloride, pH 7.4 at 37°C according to the manufacturer's
instructions, based on the spectrophotometric assay for
sphingomyelinase described by Gatt [31]. 25 μL of sphin-
gomyelinase was added to either 25 μL of 1, 5, 10 or 20
μM methylene blue (S+) or 25 μL PBS (S-) and irradiation
of the enzyme suspension was carried out using an energy
density of 1.93 J/cm2, with the appropriate controls (L-S-,
L-S+, L+S-). Experiments were performed three times in
duplicate. For laser light dose experiments, 20 μM meth-
ylene blue and energy densities of 1.93 J/cm2, 3.86 J/cm2
or 9.65 J/cm2 were used and experiments were performed
three times in triplicate
Following irradiation/dark incubation, the spectrophoto-
metric assay for sphingomyelinase activity (modifiedBMC Microbiology 2009, 9:211 http://www.biomedcentral.com/1471-2180/9/211
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from [32]) was performed. 10 μL from each sample was
removed and added to 190 μL of incubation buffer con-
taining 0.02 mg Trinitrophenylaminolauroyl-Sphingomy-
elin (TNPAL-Sphingomyelin; Sigma-Aldrich, UK), 250
mM Tris-HCl, 10 mM MgCl2 and 1% Triton X-100 in 0.5
mL Eppendorf tubes and incubated in the dark at 37°C
for 5 minutes, with shaking. 150 μL of Isopropanol:Hep-
tane:H2SO4 (40:10:1) was added to stop the reaction and
the tubes were immediately placed on ice. 100 μL of n-
heptane (Sigma-Aldrich, UK) and 80 μL deionised water
were then added and the samples were centrifuged for ten
minutes at 1398 × g. Following centrifugation, the tubes
were left to settle at room temperature for 5 minutes, after
which 60 μL of the upper layer was removed and the opti-
cal density at 330 nm recorded using a UV-VIS spectro-
photometer. A blank sample containing 10 μL incubation
buffer instead of sphingomyelinase was used as a refer-
ence.
The effect of human serum on the photosensitisation of S. 
aureus sphingomyelinase
Sphingomyelinase was diluted to a final concentration of
0.5 Units/mL in either 250 mM Tris-HCl buffer with 10
mM magnesium chloride, pH 7.4 at 37°C or the buffer
with the addition of 12.5% human serum (Sigma Aldrich,
UK) in order to model acute wound conditions and
exposed to 20 μM methylene blue and laser light with
energy densities of 1.93 J/cm2 or 9.65 J/cm2. The specto-
photometric assay for sphingomyelinase activity was per-
formed as previously described. Experiments were
performed twice in triplicate.
SDS PAGE analysis
After photosensitisation or dark incubation as previously
described, the V8 protease and α-haemolysin were ana-
lysed by sodium dodecyl sulphate polyacrylamide gel
electrophoresis (SDS PAGE). Briefly, 20 μL of each sample
was added to 5 μL reducing SDS PAGE sample buffer
(Pierce, UK) and boiled for 5 minutes to denature the pro-
tein. Samples were then analysed by SDS PAGE using a
5% stacking gel and 15% resolving gel. After electrophore-
sis, gels were placed in a fixative solution (40% methanol,
15% acetic acid) and then stained with Brilliant Blue G
(Sigma, UK). V8 protease samples were incubated on ice
with 100 mM phenylmethanesulfonyl fluoride for 30
minutes prior to SDS PAGE in order to minimise self-
digestion. The expected molecular masses of the V8 pro-
tease and α-haemolysin were given as 29 kDa and 33 kDa
respectively, as specified by the manufacturer.
Statistical analysis
Data are expressed as means ± standard error. The results
of the azocasein hydrolysis assay and sphingomyelinase
assay were analysed using the univariate ANOVA test with
Bonferroni analysis. The results from the lethal photosen-
sitisation of EMRSA-16 were analysed using the Mann
Whitney U test. For both statistical analyses, a P value of
less than 0.05 was considered statistically significant. For
photosensitiser dose experiments, the P  values refer to
samples in the absence of light versus irradiated samples.
For light dose experiments, the P values refer to samples
in the absence of methylene blue versus samples irradi-
ated in the presence of methylene blue.
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